Clinical Trial

DIalysis Symptom COntrol-Restless Legs Syndrome Trial

Study Description

DIalysis Symptom COntrol-Restless Legs Syndrome Trial

The DISCO-RLS Trial is a randomized controlled trial to determine the safety and efficacy of pharmacologic therapy (ropinirole versus placebo and gabapentin versus placebo) for the treatment of Restless Legs Syndrome in patients with End Stage Renal Disease requiring hemodialysis.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Gabapentin

100 mg capsule

Drug - Ropinirole

0.50 mg capsule

Drug - Placebo Gabapentin

Placebo capsule

Drug - Placebo Ropinirole

Placebo capsule

Additional Information

Official Study Title

DIalysis Symptom COntrol-Restless Legs Syndrome Trial (DISCO-RLS Trial): A Randomized Controlled Trial

Clinical Trial ID

NCT03806530

ParticipAid ID

dPNgla